The development of a value based pricing index for new drugs in metastatic colorectal cancer

European Journal of Cancer

Volumn 47, Issue 9, 2011, Pages 1299-1304

  Dranitsaris, George ^a,c   Truter, Ilse ^a   Lubbe, Martie S ^b  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

^c NONE   (Canada)

Author keywords

Cancer; Chemotherapy; Cost; Drug price; Value

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; FLUOROURACIL; IRINOTECAN; NEW DRUG; OXALIPLATIN;

ARTICLE; CANADA; CANCER SURVIVAL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; DRUG EFFICACY; GOVERNMENT; HUMAN; INDIA; MALAYSIA; METASTASIS; MODEL; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SIMULATION; SOUTH AFRICA; SPAIN;

EID: 79957543030     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.03.015     Document Type: Article

References (29)

1. P.R. Orszag, and P. Ellis The challenge of rising health care costs - a view from the Congressional Budget Office N Engl J Med 357 2007 1793 1795 (Pubitemid 350044798)
2. J.M. Hoffman, N.D. Shah, and L.C. Vermeulen Projecting future drug expenditures-2009 Am J Health Syst Pharm 66 2009 237 257
3. J.J. Guo, Y. Jing, and K. Nguyen Principal components analysis of drug expenditure and utilization trends for major therapeutic classes in US Medicaid programs J Med Econ 11 2008 671 694
4. P.Y. Crémieux, P. Ouellette, and P. Petit Do drugs reduce utilisation of other healthcare resources? Pharmacoeconomics 25 2007 209 221 (Pubitemid 46376831)
5. B. Wilking, and N. Jonsson A pan European comparison regarding patient access to cancer drugs 2005 Karolinska Institute and Stockholm School of Economics Stockholm
6. P.B. Bach Limits on medicare's ability to control rising spending on cancer drugs New Engl J Med 360 2009 626 633
7. Greece price cuts. < http://www.nasdaq.com/aspx/company-newsstory. aspx?storyid=201005060849dowjonesdjonline000550 >; 2010 [accessed 14.05.10].
8. Spain announces big drug price cuts, aiming for $1.6 million savings. < http://www.thepharmaletter.com/file/95032/spain-announces-big- drug-price-cuts-aiming-for-16-billion-savings.html >; 2010 [accessed 17.05.10.
9. FiercePharma. France joins European price cutting drive < http://www.fiercepharma.com/story/france-joins-european-price-cutting-drive/ 2010-06-02 >; 2010 [accessed 11.05.10].
10. Germany cuts drug industry's pricing power. < http://www.chemanager- online.com/en/news-opinions/headlines/germany-cuts-drug-industrys-pricing-power >; 2010 [accessed 24.05.10].
11. UK coalition government could end free drug pricing. http://www. forexpros.com/news/general-news/update-1-uk-coalition-govt-could-end-free-drug- pricing-139026 ; 2010 [accessed 05.05.10].
12. M.F. Drummond, and A.R. Mason European perspective on the cost and cost effectiveness of cancer therapies J Clin Oncol 25 2007 191 195 (Pubitemid 350003033)
13. B.E. Hillner, and T.J. Smith Efficacy does not necessarily translate to cost effectiveness. A case study in the challenges associated with 21st century cancer drug pricing J Clin Oncol 27 2009 2111 2113
14. C.J. Murray, D.B. Evans, A. Acharya, and R.M. Baltussen Development of WHO guidelines in generalized cost effectiveness analysis Health Econ 9 2000 235 251 (Pubitemid 30248640)
15. N. Mittmann, H.J. Au, and D. Tu Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer J Natl Cancer Inst 101 2009 1182 1192
16. UK's NICE again rejects Roche top selling cancer drug Avastin for treating metastatic colorectal cancer. < http://www.thepharmaletter.com/file/ 99882/uks-nice-again-rejects-roche-top-selling-cancer-drug-avastin-for-treating- metastatic-colorectal-cancer.html >; 2010 [accessed 18.11.10].
17. G. Dranitsaris, A. Ortega, M.S. Lubbe, and I. Truter A pharmacoeconomic modeling approach to estimate a value-based price for new oncology drugs in Europe J Oncol Pharm Pract 2011
18. M.E. Barugel, C. Vargas, and G. Krygier Waltier Metastatic colorectal cancer: recent advances in its clinical management Expert Rev Anticancer Ther 9 2009 1829 1847
19. C. Tournigand, T. Andre, and E. Achille FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 2004 229 237 (Pubitemid 41095086)
20. L.B. Saltz, S. Clarke, and E. Díaz-Rubio Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study J Clin Oncol 26 2008 2013 2019
21. G. Dranitsaris, I. Truter, M.S. Lubbe, W. Cottrell, B. Spirovski, and J. Edwards The application of pharmacoeconomic modeling to estimate a value-based price for new cancer drugs J. Eval Clin Pract 2010
22. G. Dranitsaris, I. Truter, M.S. Lubbe, N.N. Sriramanakoppa, V.M. Mendonca, and S.B. Mahagoankar Improving patient access to cancer drugs in India: Using economic modeling to estimate a more affordable drug cost based on measures of societal value Int J Technol Assess Health Care 27 2011 23 30
23. Dranitsaris G, Truter I, Lubbe MS et al. Using pharmacoeconomic modeling to determine a value based price for new pharmaceuticals in Malaysia. Presented at the 16th annual meeting of the International Society of Pharmacoeconomics and Outcomes Research, May 21-25, 2011. Baltimore, United States (submitted for publication).
24. Dranitsaris G, Truter I, Lubbe MS, Fourie S. Using measures of societal value and economic modeling to estimate prices for cancer drugs in South Africa. Presented at the 16th annual meeting of the International Society of Pharmacoeconomics and Outcomes Research, May 21-25, 2011. Baltimore, United States (submitted for publication).
25. G.W. Torrance Utility approach to measuring health-related quality of life J Chron Dis 40 1987 593 600 (Pubitemid 17084806)
26. A. Gafni Alternatives to the QALY measure for economic evaluations Support Care Cancer. 5 1997 105 111 (Pubitemid 27163450)
27. The World Fact Book. Central Intelligence Agency. < https://www.cia.gov/library/publications/the-world-factbook/rankorder/2004rank. html >; 2010 [accessed 18.11.10].
28. F.G. De Maio Income inequality measures J Epidemiol Community Health 61 2007 849 852 (Pubitemid 47492932)
29. Shashikant S. More countries use compulsory license, but new problems emerge. TWN Info Service on Health Issues No. 4. < http://www.twnside.org.sg/ title2/health.info/twninfohealth004.htm >; 2010 [accessed 27.04.10.